Psychiatry & Neurology, Clinical Neurophysiology · East Lansing, MI
NPI
1033353198
Since 2009
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
804 Service Road, Room A217
East Lansing, MI, 48824
Phone (517) 353-8122
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
453 services
Medicare patients, 2024
235
Average age 63
Drug cost, 2024
$2.0M
1,971 prescriptions
Company payments, 2025
$952
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tyson Burghardt was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 89 times for 68 patients. In total Tyson Burghardt billed 453 services in 23 codes, and Medicare paid $33K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 89 | 68 | $10.48 | $933 |
| 95720 Neurologic | Facility | 80 | 46 | $153.45 | $12K |
| 99214 Office E&M - Established | Office | 59 | 50 | $67.94 | $4,009 |
| 95816 Neurologic | Facility | 52 | 49 | $40.89 | $2,126 |
| 99213 Office E&M - Established | Office | 50 | 46 | $54.00 | $2,700 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $125.55 | $2,260 |
| 95718 Neurologic | Facility | 14 | 14 | $101.51 | $1,421 |
| 99215 Office E&M - Established | Office | 14 | 11 | $78.43 | $1,098 |
By year: 2022 $40K for 434 services; 2023 $45K for 464 services; 2024 $33K for 453 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tyson Burghardt prescribed most often to Medicare patients was Lacosamide, with 203 prescriptions and refills. In total Tyson Burghardt wrote 1,971 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 203 | 354 | 51 | $26K |
| Lamotrigine Generic | 189 | 355 | 45 | $4,918 |
| Levetiracetam Generic | 186 | 428 | 62 | $12K |
| Xcopri Cenobamate | 180 | 193 | 29 | $247K |
| Briviact Brivaracetam | 149 | 159 | 19 | $270K |
| Clobazam Generic | 104 | 135 | 20 | $8,691 |
| Zonisamide Generic | 87 | 210 | 30 | $4,873 |
| Epidiolex Cannabidiol (Cbd) | 78 | 82 | 11 | $464K |
| Aptiom Eslicarbazepine Acetate | 59 | 79 | 11 | $136K |
| Clonazepam Generic | 48 | 64 | 14 | $535 |
| Lamotrigine Er Lamotrigine | 47 | 77 | 13 | $12K |
| Topiramate Generic | 45 | 83 | 13 | $564 |
| Lorazepam Generic | 39 | 44 | 13 | $282 |
| Gabapentin Generic | 37 | 77 | 12 | $1,258 |
| Oxcarbazepine Generic | 34 | 84 | Under 11 | $2,774 |
Brand drugs: 625 claims; generic drugs: 1,320 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tyson Burghardt $952 ($952 in general payments such as food, travel and fees) from 22 companies. The largest payer was UCB, Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 8 | $144 |
| Abbvie Inc. ABBV | 4 | $95.41 |
| Catalyst Pharmaceuticals, Inc. CPRX | 3 | $75.09 |
| Otter Pharmaceuticals, LLC | 2 | $60.73 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $59.31 |
| Aucta Pharmaceuticals, Inc. | 3 | $57.8 |
| Argenx US, Inc. ARGX | 2 | $57.8 |
| Biogen, Inc. BIIB | 2 | $52.58 |
| Kedrion Biopharma, Inc. | 2 | $38.75 |
| Axsome Therapeutics, Inc. AXSM | 1 | $34.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.